BioCentury
ARTICLE | Clinical News

MiR-29: Phase I started

December 7, 2015 8:00 AM UTC

miRagen began a double-blind, placebo-controlled, Canadian Phase I trial of MRG-201 in about 80 healthy volunteers and patients. In the first part, volunteers will receive single and multiple ascendin...